For the Inventor, By the Inventor

Enter assignee name

Parkville, Australia

Walter and Eliza Hall Institute of Medical Research

USPTO Granted Patents = 83

CIPO Patents = 9

EPO Patents = 30

Forward Citations = 357

Loading Chart...

Loading Chart...

218 inventors (with patents filed for the assignee):

Sandra Elaine Nicholson (12 out of 13 patents)

Leonard Charles Harrison (9 out of 12 patents)

Jonathan Bayldon Baell (8 out of 28 patents)

4. Andrew J Souers (8 out of 63 patents)

5. Steven Elmore (8 out of 54 patents)

6. Guillaume Laurent Lessene (8 out of 10 patents)

7. Douglas James Hilton (7 out of 23 patents)

8. Nicos Anthony Nicola (7 out of 23 patents)

9. Brian John Smith (7 out of 8 patents)

10. Alan E Cowman (7 out of 7 patents)

11. Yuxia Zhang (6 out of 6 patents)

12. Peter Colman (6 out of 6 patents)

13. Keith G Watson (6 out of 61 patents)

14. Nicholas D Huntington (5 out of 5 patents)

15. Esther Bandala Sanchez (5 out of 5 patents)

Core Competencies:

Insulin Analogs

Antimalarial Agents

Apoptosis Inducing Agents

Malaria Vaccine

Cytokine Inhibition

Dendritic Cell Markers

Protein Kinase Inhibitors

Therapeutic Pro-Apoptotic Molecules

Intracellular Infection Treatment

Immunogenic Compositions

Cancer Treatment

Heterocyclic Compounds

83 patents: Sort by Forward Citations

1. 12410228 - Insulin analogs (2025-09-09),

2. 12350270 - Antimalarial agents (2025-07-08),

3. 12338219 - Antimalarial agents (2025-06-24),

4. 12259387 - System, method, apparatus and diagnostic test for plasmodium vivax (2025-03-25),

5. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2024-02-13),

6. 11835520 - System, method, apparatus and diagnostic test for (2023-12-05),

7. 11779639 - Parasite vaccine (2023-10-10),

8. 11766435 - N3-substituted iminopyrimidinones as antimalarial agents (2023-09-26),

9. 11492404 - Inhibition of cytokine-induced SH2 protein in NK cells (2022-11-08),

10. 11339220 - Inhibition of cytokine-induced SH2 protein in NK cells (2022-05-24),

11. 11326134 - Barley with low levels of hordeins (2022-05-10),

12. 11279760 - Inhibition of cytokine-induced SH2 protein in NK cells (2022-03-22),

13. 11248034 - Insulin analogs (2022-02-15),

14. 11123403 - Soluble mediator (2021-09-21),

15. 11104735 - Inhibition of cytokine-induced SH2 protein in NK cells (2021-08-31),

The Walter and Eliza Hall Institute of Medical Research (WEHI) is Australia's oldest medical research institute. Established in 1915, WEHI is located in Melbourne and has made significant contributions to improving global health and shaping healthcare practices. The institute specializes in diverse areas of medical research, including cancer and infectious diseases. WEHI focuses on investigating fundamental biological processes and translating discoveries into clinical applications. With a commitment to excellence and collaboration, WEHI continues to drive advancements in medical science and improve the well-being of communities worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

83 Patents

#2 in

#34 in

#8,901 in the World

Parkville, Australia

Walter and Eliza Hall Institute of Medical Research

Forward Citations = 357

218 inventors:

Sandra Elaine Nicholson (12 out of 13 patents)

Leonard Charles Harrison (9 out of 12 patents)

Jonathan Bayldon Baell (8 out of 28 patents)

4. Andrew J Souers (8 out of 63 patents)

5. Steven Elmore (8 out of 54 patents)

Please report any incorrect information to support@idiyas.com

Loading…